Implementation costs of screening and brief intervention for illicit drug use by Bray, Jeremy W. & NC DOCKS at The University of North Carolina at Greensboro
Implementation costs of screening and brief intervention for illicit drug use 
 
By: Gary Zarkin, Jeremy W. Bray, Jesse Hinde, Richard Saitz 
 
Zarkin, G.A., Bray, J.W., Hinde, J.M., & Saitz, R. (2013). Implementation costs of screening and 
brief intervention for illicit drug use. Addiction Science & Clinical Practice, 8(Suppl 1), A88. 
 
This work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License. 
 
The electronic version of this article is the complete one and can be found online 
at: http://www.ascpjournal.org/content/8/S1/A88.  
 
Abstract: 
 
From International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) 
Meeting 2013 Rome, Italy. 18-20 September 2013. 
 
Keywords: screening and brief intervention (SBI) | illicit drug use | cost  
 
Article:  
 
***Note: Full text of article below 
 
MEETING ABSTRACT Open Access
Implementation costs of screening and brief
intervention for illicit drug use
Gary Zarkin1*, Jeremy Bray2, Jesse Hinde1, Richard Saitz3
From International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) Meeting 2013
Rome, Italy. 18-20 September 2013
In 2008, a World Health Organization multi-national
clinical trial found screening and brief intervention (SBI)
to be effective in reducing illicit drug use and many have
called for its widespread dissemination. To gain policy
support for widespread dissemination, however, a strong
business case must be made to policymakers. In particular,
policymaker concerns over implementation costs can act
as a significant obstacle to widespread dissemination. This
presentation estimates the various cost components of
providing SBI to reduce illicit drug use in a primary care
setting as part of the clinical trial Assessing Screening
Plus brief Intervention’s Resulting Efficacy (ASPIRE). An
activity-based micro-costing approach was used to deter-
mine implementation costs and set-up costs. Implementa-
tion costs include variable costs (direct costs that directly
vary by the number of services provided) and quasi-fixed
costs (service-support costs that indirectly vary by the
number of services provided). Set-up costs are fixed costs
incurred to the program, such as the purchase of durable
equipment and initial training. A taxonomy of activities
and resource inputs (labor, material and space) were iden-
tified. Quantity and most price values were obtained
through primary data collection during the trial. Regional
price estimates for wages and space were used where
needed. Preliminary estimates indicate that variable costs
to provide SBI for unhealthy drug use are similar to SBI
programs focusing on alcohol. Quasi-fixed costs are sub-
stantially higher than variable costs for this program.
Quasi-fixed costs are not usually estimated; the focus is
usually on variable costs of service delivery. This study fills
a gap in the economic literature on SBI regarding quasi-
fixed costs. These findings have important implications for
the adoption and sustainability of SBI programs, where
focusing only on variable costs underestimates the fiscal
impact of implementing SBI.
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